RxDoctor Payments Data

Ellen Weiss

Optometrist · Omaha, NENPI 1982754966

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (48.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 57.7% of the total. Reporting peaked in 2019 at $1,927 and has fallen 93.1% since, to $133 in 2025. Among optometrist clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,273in general payments, 2019–2025

Across 48 payments — averaging $68.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Alcon$415
  • Bausch & Lomb Americas Inc.$244
  • Coopervision Inc.$139
  • LKC Technologies, Inc.$126
  • AbbVie$124
  • plus $338 from 5 others

What the payments were for

  • Speaking & faculty fees$2508%
  • Travel & lodging$1,57648%
  • Food & beverage$1,44744%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,273 in reported general payments places this provider in the 90th percentile of 383 optometrist providers in Nebraska.

See all optometrist providers in Nebraska

Medicare billing

Part B allowed, 2024
$22,939
Medicare patients
154
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost17$312

Paid to pharmacies, not to this prescriber.

Other optometrist in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →